Immune System News and Research

RSS

Repro-Med Systems receives FDA marketing approval for new subcutaneous needle sets

Repro-Med Systems, Inc., announced today that it has received approval from the Food and Drug Administration to begin U.S. marketing of its new Subcutaneous Needle Sets which the company is promoting as the HIgh Flo RMS Subcutaneous Needle Sets.

1 Jun 2011

Appendix and tonsil surgeries before age 20 can increase risk of premature heart attack

The surgical removal of the appendix and tonsils before the age of 20 was associated with an increased risk of premature heart attack in a large population study performed in Sweden. Tonsillectomy increased the risk by 44% (hazard ratio 1.44) and appendectomy by 33% (HR 1.33).

1 Jun 2011

Lymphoma vaccine extends disease-free survival by 14 months

A lymphoma vaccine uniquely tailored for each patient extends disease-free survival by 14 months, with signs of an even better response for patients with a specific biological marker, a team led by scientists at The University of Texas MD Anderson Cancer Center reported today in the online version of Journal of Clinical Oncology.

1 Jun 2011

At the 30 year mark, AIDS epidemic still poses challenges

Thirty years after America started battling HIV/AIDS, deaths linked to the virus have plummeted. New HIV cases are down by three-quarters. Life expectancy has more than tripled. Many HIV-positive people lead active lives, often on a single pill a day. But there's a darker side: More than 1.2 million Americans still are living with HIV/AIDS, and 40,000 new infections and 16,000 deaths are expected this year.

1 Jun 2011

Rochester receives $1M FDA, BDRSA grant to begin first controlled clinical trial in Juvenile Batten disease

After years of building hope for a treatment, Rochester researchers and clinicians will begin the first controlled clinical trial for Juvenile Batten disease this summer, thanks to $1 million in grants from the Food and Drug Administration and the Batten Disease Support and Research Association.

1 Jun 2011

Eculizumab effective for treating hemolytic-uremic syndrome from EHEC

In the online version of the New England Journal of Medicine, physicians and scientists in Heidelberg, Montreal, and Paris reported on the successful treatment of three young children who were suffering from a severe hemolytic-uremic syndrome after an infection with enterohemorrhagic Escherichia coli.

1 Jun 2011

Ampio commences new anti-inflammatory agent Phase 1B trial in osteoarthritis

Ampio Pharmaceuticals, Inc. announced today that it received ethics board approval for a Phase 1B clinical trial in Australia of its biologic anti-inflammatory agent, Ampion.

1 Jun 2011

Increased stress not linked to multiple sclerosis

According to a new study that refutes earlier evidence, stress does not appear to increase a person's risk of developing multiple sclerosis (MS). The research is published in the May 31, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

31 May 2011

Scientists develop carbohydrate-based vaccine against C. difficile infection

There is now a promising vaccine candidate for combating the pathogen which causes one of the most common and dangerous hospital infections. An international team of scientists from the Max Planck Institute of Colloids and Interfaces in Potsdam has developed a vaccine based on a carbohydrate against the Clostridium difficile bacterium, which is known to cause serious gastrointestinal diseases mainly in hospitals.

31 May 2011

Study finds novel site within MS4A gene cluster, confirms presence of SNP linked with Alzheimer's

Recently the number of genes known to be associated with Alzheimer's disease has increased from four to eight, including the MS4A gene cluster on chromosome 11.

31 May 2011

Study suggests new therapeutic targets for virally-induced asthma attacks

When children with asthma get the flu, they often land in the hospital gasping for air. Researchers at Children's Hospital Boston have found a previously unknown biological pathway explaining why influenza induces asthma attacks.

30 May 2011

Positive data from Augurex's RA biomarker blood test, novel drug target presented at EULAR conference

Augurex Life Sciences Corp. today reported that in London at the European League Against Rheumatism Conference, leading arthritis researchers presented important data on Augurex's rheumatoid arthritis biomarker blood test and novel drug target.

30 May 2011

Scientists identify new molecular pathway that may combat retinal disease, cancers

Scientists identify in the journal Nature a new molecular pathway used to suppress blood vessel branching in the developing retina - a finding with potential therapeutic value for fighting diseases of the retina and a variety of cancers.

30 May 2011

Vitamin D levels low in African Americans with multiple sclerosis

In the first major study exploring the connection between vitamin D and multiple sclerosis in African Americans, a team of scientists at the University of California, San Francisco has discovered that vitamin D levels in the blood are lower in African Americans who have the disease, compared to African Americans who do not.

30 May 2011

Flu vaccines at the ready this season

Manufacturers of flu vaccines are nearly ready with the new supply of vaccinations for this upcoming flu season in the northern hemisphere. Two weeks ago, five vaccine manufacturers announced plans to make between 166 million and 173 million doses for the coming season. That's at least 6 million more than the maximum ever produced. However they add that many might not actually need the shots.

29 May 2011

IDF applauds Representatives for Medicare IVIG Access Act

The Immune Deficiency Foundation applauds Representatives Kevin Brady and Doris Matsui and Senators John Kerry and Lamar Alexander for introducing H.R. 1845 and S. 960, both entitled the Medicare IVIG Access Act.

27 May 2011

Tacrolimus prevents breast cancer growth in pre-clinical studies

Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th PLoS ONE.

27 May 2011

Longer looks: Stem cells, vaccinating against addictive drugs, the GOP's budget hatchet man

Krista and Tatiana are not like most other sets of twins. They are connected at their heads, where their skulls merge under a mass of shaggy brown bangs. The girls run and play and go down their backyard slide, but whatever they do, they do together, their heads forever inclined toward each other's, their neck muscles strong and sinuous from a never-ending workout. Twins joined at the head — the medical term is craniopagus — are extremely rare.

27 May 2011

Specific influenza immunization strategies for RA patients may be required for future flu pandemics

A Brazilian hospital-based study assessed responses to flu vaccines in 340 RA patients in regular follow-up compared to 234 healthy patients.

26 May 2011

NWBT accelerates addition of clinical sites for new enrollment into ongoing GBM brain cancer trial

Northwest Biotherapeutics today announced that it has accelerated the addition of clinical trial sites, exceeding its projections for the doubling of such sites across the U.S. this calendar quarter, for enrollment of new patients into the Company's ongoing 240-patient randomized, double blind, placebo controlled clinical trial of DCVax immune therapy for Glioblastoma multiforme, the most lethal form of brain cancer.

26 May 2011

Immune System News and Research

Repro-Med Systems receives FDA marketing approval for new subcutaneous needle sets

Appendix and tonsil surgeries before age 20 can increase risk of premature heart attack

Lymphoma vaccine extends disease-free survival by 14 months

At the 30 year mark, AIDS epidemic still poses challenges

Rochester receives $1M FDA, BDRSA grant to begin first controlled clinical trial in Juvenile Batten disease

Eculizumab effective for treating hemolytic-uremic syndrome from EHEC

Ampio commences new anti-inflammatory agent Phase 1B trial in osteoarthritis

Increased stress not linked to multiple sclerosis

Scientists develop carbohydrate-based vaccine against C. difficile infection

Study finds novel site within MS4A gene cluster, confirms presence of SNP linked with Alzheimer's

Study suggests new therapeutic targets for virally-induced asthma attacks

Positive data from Augurex's RA biomarker blood test, novel drug target presented at EULAR conference

Scientists identify new molecular pathway that may combat retinal disease, cancers

Vitamin D levels low in African Americans with multiple sclerosis

Flu vaccines at the ready this season

IDF applauds Representatives for Medicare IVIG Access Act

Tacrolimus prevents breast cancer growth in pre-clinical studies

Longer looks: Stem cells, vaccinating against addictive drugs, the GOP's budget hatchet man

Specific influenza immunization strategies for RA patients may be required for future flu pandemics

NWBT accelerates addition of clinical sites for new enrollment into ongoing GBM brain cancer trial

Immunology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News